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What’s the best test for renal  
artery stenosis in patients 
with refractory hypertension?
Evidence-based answer
Magnetic	resonance	angiography	(MrA)	
and	computed	tomography	angiography	
(CTA)	are	the	most	consistently	accurate,	
noninvasive	screening	methods.	MrA	is	
likely	the	preferred	option	because	of	its	lack	
of	radiation	and	reduced	risk	of	contrast	
media	(strength	of	recommendation	[sor]:	
A,	large	meta-analyses).	
z Evidence summary
Significant renal artery stenosis (RAS) 
is defined anatomically as >50% steno-
sis of the lumen by renal angiography; 
stenosis is considered hemodynamically 
significant (potentially causing renovas-
cular hypertension) if it exceeds 75%.1 
The prevalence of renovascular hyper-
tension among the general hypertensive 
population varies from 1% to 5%. The 
prevalence increases to 20% to 40% in 
the presence of certain clinical criteria:
•  hypertension in patients <30 years
•  worsening or sudden onset of hy-
pertension in patients >50 years
•  hypertension refractory to multiple 
medications
• malignant hypertension
• worsening renal function after 
starting an angiotensin-converting en-
zyme inhibitor (ACE-I).2,3 (Worsening re-
nal function is defined as >30% decline 
in estimated glomerular filtration rate or 
>30% increase in serum creatinine during 
the first 2 months of ACE-I therapy.1) 
Refractory hypertension associated 
with generalized atherosclerosis is the 
most predictive risk factor for RAS.
MRA is usually best,  
but don’t overlook ultrasound
Among the primary diagnostic tests 
for RAS (see TABLE W1 on page 216a), 
MRA is the most consistently accurate4 
and least operator dependent—which 
makes it the best choice in most situa-
tions. One rare but serious concern with 
MRA is that contrast agents may cause 
nephrogenic systemic fibrosis (NSF), 
a debilitating and sometimes fatal dif-
fuse disease affecting the skin, muscle, 
and internal organs. In 2006, 25 cases 
of NSF after exposure to gadolinium-
based contrast agents were reported, 
prompting an FDA warning.5 
Kidney duplex Doppler ultrasound 
can rival MRA and CTA in accuracy, but 
is highly operator dependent. If access to 
highly skilled, experienced technicians is 
available, this safe and less expensive op-
tion can be considered, especially for pa-
tients with chronic kidney disease.
Recommendations
The American College of Radiology recom-
mends stratifying patients into 3 groups:
•  high index of suspicion with nor-
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Kidney duplex 
Doppler ultrasound 
can rival MRA and 
CTA in accuracy, 
but is highly  
operator  
dependent.
mal renal function 
•  high index of suspicion with dimin-
ished renal function 
•  low index of suspicion. 
Recommendations include: 
•  MRA or CTA for high suspicion 
with normal renal function 
•  MRA or ultrasonography for high 
suspicion with impaired renal 
function
•  All methods equally inappropriate 
if suspicion is low.3 
Cost-effectiveness was not evaluated 
in the meta-analysis used to derive the 
guidelines.
The National Kidney Foundation 
recommends MRA and CTA as accu-
rate, noninvasive, and consistent means 
of diagnosing RAS. The foundation also 
recommends duplex ultrasonography as 
a less invasive and less expensive alterna-
tive when local expertise is available. The 
guidelines include a moderately predictive 
rule for identifying patients who should 
be screened for renovascular hyperten-
sion—that is, patients with intermediate 
or high pretest probability (www.kidney.
org/professionals/kdoqi/guidelines_bp/
guide_4.htm).1
The American College of Cardiology 
and the American Heart Association list 
advantages and disadvantages of each 
diagnostic method and recommend 
choosing the one that is best suited to 
the patient.6 n
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•  Do abnormal fetal kick counts predict intrauterine death  
    in average-risk pregnancies? 
•   What is the role of prokinetic agents for constipation?
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Diagnostic tests for renovascular hypertension
TEsT
comPosiTE 
rATing sEnsiTiviTy sPEcificiTy sPEciAl considErATions
mrA 1 94%-97%4 85%-93%4 no	radiation;	expensive;	small	risk	of		
nephrogenic	systemic	fibrosis	from	gadolinium	
contrast	agents
cTA 2 88%-96%3 77%-98%3 similar	accuracy	to	MrA;	moderate	radiation	
exposure;	requires	iodinated	contrast	media
us duplex 
doppler
3 0%-90%3 95%3 noninvasive;	highly	operator	dependent
AcE-i  
renography/ 
scintography
4 58%-95%2 17%-100%2 noninvasive;	can	be	used	in	renal	insufficiency;	
high	radiation	exposure;	literature	is	not	uniform	
regarding	techniques	and	interpretation	criteria
invasive  
arteriography
5 — — Gold	standard;	invasive;	better	used		
as	confirmation	than	screening
invasive  
renal vein renin 
assays
6 65%-74%3 100%3 Good	confirmatory	test;	invasive;	possibility		
of	sampling	error
ACe-I,	angiotensin-converting	enzyme	inhibitor;	CTA,	computed	tomography	angiography;	MrA,	magnetic	resonance	angiography;	us,	ultrasound.	
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